BioStock: PHI’s CEO comments on the approved US listing

August 21, 2024
Language flag

Phase Holographic Imaging has been approved for a dual US listing in addition to its primary listing on the Swedish Spotlight market. What does this mean for the company’s shareholders, and how might it impact the company’s long-term valuation? BioStock reached out to PHI’s CEO Patrik Eschricht to discuss this and the upcoming redemption of the TO4 warrants that could potentially raise SEK 20.8 million in October.

Read the full interview with Patrik Eschricht on biostock.se.

The dual listing on the OTCQB market represents a significant step in
making PHI’s shares more accessible to US investors. This listing
increases our visibility in the US, aligning with our strategic focus on
expanding into the regenerative medicine market.

Further reading

phi-right-moment-to-capitalize-on-regenerative-medicine-momentum

BioStock: PHI “It’s the right moment to capitalize on regenerative medicine momentum.”

BioStock contacted CEO Patrik Eschricht for an update on the company’s progress and how PHI will capitalize on the current momentum.
PHI-biostock-shift-to-regenerative-medicine-increases-growth-prospects-for-phi

BioStock: Shift to regenerative medicine increases growth prospects for PHI

BioStock talked to our CEO, Patrik Eschricht, for an operational overview and to learn about the current behind-the-scenes developments, as PHI has a growth trajectory that is on a notable upward trend, marked by its highest-ever sales performances in the last quarter.
Biostock PHI one year CEO anniversary

BioStock: PHI “We aim to revolutionize the regenerative medicine market“

BioStock talked to PHI’s CEO, Patrik Eschricht, about the eventful past year and his vision for the company’s future within regenerative medicine.
BioStock-PHI-CEO-reflects-on-the-company-momentum

BioStock: PHI’s CEO reflects on the Company’s momentum

BioStock reached out to PHI’s CEO, Patrik Eschricht, to delve into what latest developments have contributed to the heightened enthusiasm surrounding the company.
1…34567…10

Latest News

PHI publishes prospectus due to upcoming rights issue
Biostock-Phase-Holographic-Imaging-1280px-Anders-Goran

BioStock: Studio interview with Anders Månsson and Goran Dubravčić

Recently, PHI welcomed Anders Månsson as its new CEO. In a video interview, Månsson and Chairman of the Board Goran Dubravčić discuss the company’s future strategy and the ongoing rights issue.

Bulletin from extraordinary general meeting in Phase Holographic Imaging PHI AB (publ) 2 December 2024

Today, 2 December 2024, an Extraordinary General Meeting was held in Phase Holographic Imaging PHI AB (publ), 556542-7811 (the “Company”). The adopted resolution is summarized below.
See All News